Overlap of Autoimmune Hepatitis and Primary Biliary Cirrhosis: Long-Term Outcomes

Silveira, Marina G.; Talwalkar, Jayant A.; Angulo, Paul; Lindor, Keith D.
June 2007
American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1244
Academic Journal
BACKGROUND: The coexistence of primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH) has been called “overlap syndrome,” but diagnosis is challenging and the natural history of this syndrome has not been demonstrated. The importance of the diagnosis of PBC-AIH overlap is due to potential therapeutic options. Patients with PBC should receive ursodeoxycholic acid (UDCA); the role of and response to additional immunosuppressive therapy are unknown when AIH overlaps PBC. METHODS AND RESULTS: We reviewed 135 patients with PBC according to a revised scoring system proposed by the International Autoimmune Hepatitis Group (IAHG). Twenty-six patients had features of PBC-AIH overlap and 109 did not. Mean follow-up was 6.1 yr for overlap syndrome patients and 5.4 yr in PBC patients. There was a higher rate of portal hypertension ( P= 0.01), esophageal varices ( P < 0.01), gastrointestinal (GI) bleeding ( P= 0.02), ascites ( P < 0.01), and death and/or orthotopic liver transplantation (OLT) ( P < 0.05) in the overlap group. CONCLUSION: In conclusion, esophageal varices, GI bleeding, ascites, and death and/or OLT were more common in the overlap group. The higher risk of symptomatic portal hypertension and worse outcomes in patients with PBC overlap syndrome may justify the risks of immunosuppressive therapy. Large randomized studies are necessary to establish optimal therapeutic strategies.


Related Articles

  • A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. Yamamoto, Kazuhide; Terada, Ryo; Okamoto, Ryoichi; Hiasa, Youichi; Abe, Masanori; Onji, Morikazu; Tsuji, Takao // Journal of Gastroenterology;2003, Vol. 38 Issue 1, p52 

    Background. Although primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH) are two independent autoimmune liver diseases, it is sometimes difficult to characterize the variant forms of autoimmune liver disease. A PBC scoring system, in combination with the AIH scoring system may be...

  • Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome. Rigopoulou, Eirini I.; Zachou, Kalliopi; Gatselis, Nikolaos; Koukoulis, George K.; Dalekos, George N. // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2014, Vol. 13 Issue 1, p127 

    We retrospectively investigated the characteristics, patterns of disease progression, outcome and difficulties in the management in 11 patients with concurrent autoimmune hepatitis (AIH) and HBV or HCV infections (5 HCV and 6 HBV including 2 with HDV co-infection) since there are scarce data on...

  • POSTHEPATITIC CIRRHOSIS. Spain, David M. // American Journal of Gastroenterology;Oct1955, Vol. 24 Issue 4, p428 

    Presents information on posthepatitic cirrhosis. Incidence of posthepatitic cirrhosis; Forms of posthepatitic cirrhosis; Relationship of posthepatitic cirrhosis with other forms.

  • Successful Pregnancy in Autoimmune Hepatitis/Primary Biliary Cirrhosis Overlap Syndrome: A Case Report. Mitra, Subarna; Nayak, Prasanta Kumar; Padma, Alaganandam; Kurian, George // Gastroenterology Research;2012, Vol. 5 Issue 5, p208 

    Medical literature on pregnancy outcomes in hepatic overlap syndromes is limited. Autoimmune liver diseases are associated with sub-fertility and pregnancy is usually dissuaded in presence of portal hypertension and cirrhosis due to guarded prognosis for the pregnancy as well as the liver...

  • Early Administration of Vapreotide for Variceal Bleeding in Patients with Cirrhosis. Calès, Paul; Masliah, Claude; Bernard, Brigitte; Garnier, Pierre-Philippe; Silvain, Christine; Bronowicki, Jean-Pierre; Szostak-Talbodec, Nathalie; Ribard, Didier; Botta-Fridlund, Danièle; Hillon, Patrick; Besseghir, Kamel; Lebrec, Didier; Poynard, Thierry; Verger, Pierre; Paris, Jean-Claude; Durand, Francois; Valla, Dominique-Charles; Lemaire, Alex; Rouch, Michel; Blanchi, Alain // New England Journal of Medicine;01/04/2001, Vol. 344 Issue 1, p23 

    Background: In patients with cirrhosis, pharmacologic or endoscopic treatment may control variceal bleeding. However, the effects of early administration of a somatostatin analogue followed by endoscopic treatment are unknown. Methods: We studied the effects of treatment with vapreotide, a...

  • Optimizing Therapeutics: The Next Front in the War on Rheumatoid Arthritis. Edison, J D; Gilliland, W R // Clinical Pharmacology & Therapeutics;Apr2012, Vol. 91 Issue 4, p561 

    The authors reflect on the optimization of the therapeutics for rheumatoid arthritis (RA). They have said that the emergence of radical novel therapeutics in RA have manifested that patient outcomes are enhanced which have challenged and changed the traditional treatment paradigms used for RA....

  • Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye. Vitale, Susan; Goodman, Linda A.; Reed, George F.; Smith, Janine A. // Health & Quality of Life Outcomes;2004, Vol. 2, p44 

    Background: To examine the associations between vision-targeted health-related quality of life (VT-HRQ) and ocular surface parameters in patients with Sjögren's syndrome, a systemic autoimmune disease characterized by dry eye and dry mouth. Methods: Forty-two patients fulfilling European /...

  • Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. Lleo, Ana; Shimoda, Shinji; Ishibashi, Hiromi; Gershwin, M. // Journal of Gastroenterology;Jan2011, Vol. 46, p29 

    utoimmune liver diseases (ALDs) represent a wide spectrum of chronic inflammatory diseases that are characterized by an immune-mediated attack against either hepatocytes (in the case of autoimmune hepatitis types 1 and 2, AIH-1, 2) or cholangiocytes (in primary biliary cirrhosis, PBC). PBC is...

  • Autoimmune liver disease - are there spectra that we do not know?  // Comparative Hepatology;2011, Vol. 10 Issue 1, p9 

    The article offers information on a research that discusses autoimmune liver diseases (AILDs). It is mentioned that primary biliary cirrhosis is a common example of AILD which is characterized by the presence of antimitochondrial antibody and can be managed by daily dose of ursodeoxycholic acid...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics